Denver Health and Hospital Authority, Denver, Colorado, USA.
VA Eastern Colorado Health Care System, Aurora, Colorado, USA.
Acad Emerg Med. 2021 Jun;28(6):621-629. doi: 10.1111/acem.14198. Epub 2021 Jan 29.
We describe the Columbia-Suicide Severity Rating Scale (C-SSRS)-Clinical Practice Screener's ability to predict suicide and emergency department (ED) visits for self-harm in the year following an ED encounter.
Screening data from adult patients' first ED encounter during a 27-month study period were analyzed. Patients were excluded if they died during the encounter or left without being identified. The outcomes were suicide as reported by the state health department and a recurrent ED visit for suicide attempt or self-harm reported by the state hospital association. Multivariable regression examined the screener's correlation with these outcomes.
Among 92,643 patients analyzed, eleven (0.01%) patients died by suicide within a month after ED visit. The screener's sensitivity and specificity for suicide by 30 days were 0.18 (95% confidence interval [CI] = 0.00 to 0.41) and 0.99 (95% CI = 0.99 to 0.99). Sensitivity and specificity were better for predicting self-harm by 30 days: 0.53 (95% CI = 0.42 to 0.64) and 0.97 (95% CI = 0.97 to 0.97), respectively. Multivariable regression demonstrated that screening risk remained associated with both suicide and self-harm outcomes in the presence of covariates. Suicide risk was not mitigated by hospitalization or psychiatric intervention in the ED.
The C-SSRS screener is insensitive to suicide risk after ED discharge. Most patients who died by suicide screened negative and did not receive psychiatric services in the ED. Moreover, most patients with suicidal ideation died by causes other than suicide. The screener was more sensitive for predicting nonfatal self-harm and may inform a comprehensive risk assessment. These results compel us to reimagine the provision of emergency psychiatric services.
我们描述了哥伦比亚-自杀严重程度评定量表(C-SSRS)-临床实践筛查器预测自杀和自残后一年内急诊科(ED)就诊的能力。
分析了 27 个月研究期间成年患者首次 ED 就诊时的筛查数据。如果患者在就诊期间死亡或未被识别而离开,则将其排除在外。结局是由州卫生部门报告的自杀和由州医院协会报告的自杀未遂或自残的再次 ED 就诊。多变量回归分析了筛查器与这些结局的相关性。
在分析的 92643 名患者中,有 11 名(0.01%)患者在 ED 就诊后一个月内自杀死亡。筛查器在 30 天内预测自杀的灵敏度和特异性分别为 0.18(95%置信区间 [CI] 0.00 至 0.41)和 0.99(95% CI 0.99 至 0.99)。预测 30 天内自残的灵敏度和特异性更好:0.53(95% CI 0.42 至 0.64)和 0.97(95% CI 0.97 至 0.97)。多变量回归表明,在存在协变量的情况下,筛查风险仍然与自杀和自残结局相关。ED 中的住院或精神病干预并不能减轻自杀风险。
C-SSRS 筛查器对 ED 出院后自杀风险不敏感。大多数自杀死亡的患者筛查结果为阴性,且未在 ED 中接受精神科服务。此外,大多数有自杀意念的患者死于自杀以外的原因。该筛查器对预测非致命性自残更敏感,可能为全面风险评估提供信息。这些结果促使我们重新构想紧急精神科服务的提供方式。